S&P 500 Futures
(-0.13%) 5 139.25 points
Dow J Futures
(-0.22%) 39 057 points
Nasdaq Futures
(-0.04%) 18 332 points
Oil
(-0.28%) $79.75
Gas
(2.83%) $1.887
Gold
(-0.09%) $2 093.80
Silver
(0.00%) $23.37
Platinum
(1.25%) $899.10
USD/EUR
(-0.11%) $0.922
USD/NOK
(0.14%) $10.52
USD/GBP
(-0.16%) $0.789
USD/RUB
(-0.38%) $91.33

Realtime updates for Vir Biotechnology Inc [VIR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
83.33%
return 2.62%
SELL
83.33%
return -11.12%
Last Updated1 Mar 2024 @ 16:00

0.00% $ 11.24

BUY 26886 min ago

@ $9.72

Issued: 14 Feb 2024 @ 13:10


Return: 15.64%


Previous signal: Feb 14 - 09:30


Previous signal: Sell


Return: 6.58 %

Live Chart Being Loaded With Signals

Commentary (1 Mar 2024 @ 16:00):
Profile picture for Vir Biotechnology Inc

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus...

Stats
Today's Volume 1.22M
Average Volume 1.19M
Market Cap 1.52B
EPS $0 ( 2024-02-22 )
Next earnings date ( $-0.990 ) 2024-05-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.45
ATR14 $0.0160 (0.14%)
Insider Trading
Date Person Action Amount type
2024-02-22 Hanly Ann M. Buy 32 500 Common Stock
2024-02-22 Hanly Ann M. Sell 12 296 Common Stock
2024-02-22 Hanly Ann M. Buy 65 000 Stock Option (Right to Buy)
2024-02-22 De Backer Marianne Buy 175 000 Common Stock
2024-02-22 De Backer Marianne Buy 350 000 Stock Option (Right to Buy)
INSIDER POWER
-9.56
Last 98 transactions
Buy: 8 177 990 | Sell: 9 703 750

Volume Correlation

Long: -0.53 (weak negative)
Short: 0.59 (weak)
Signal:(48.084) Neutral

Vir Biotechnology Inc Correlation

10 Most Positive Correlations
MMAC0.954
BOCH0.943
NETE0.913
SHSP0.859
AMRB0.843
RAVN0.843
SILC0.824
DSPG0.802
10 Most Negative Correlations
PAIC-0.934
RMRM-0.927
SVOK-0.922
SVAC-0.888
ISNS-0.888
APOP-0.887
FEYE-0.874
GAINL-0.872
SPRT-0.837
TDAC-0.828

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vir Biotechnology Inc Correlation - Currency/Commodity

The country flag 0.27
( neutral )
The country flag 0.16
( neutral )
The country flag 0.00
( neutral )
The country flag 0.08
( neutral )
The country flag 0.00
( neutral )
The country flag -0.31
( neutral )

Vir Biotechnology Inc Financials

Annual 2023
Revenue: $86.18M
Gross Profit: $83.42M (96.79 %)
EPS: $-0.0046
Q4 2023
Revenue: $56.29M
Gross Profit: $55.49M (98.58 %)
EPS: $-0.0009
Q3 2023
Revenue: $-4.10M
Gross Profit: $-4.14M (100.93 %)
EPS: $-1.220
Q2 2023
Revenue: $-12.72M
Gross Profit: $-12.74M (100.17 %)
EPS: $-1.450

Vir Biotechnology Inc

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators